Logo image of EVA.MI

ASKOLL EVA SPA (EVA.MI) Stock Fundamental Analysis

BIT:EVA - Euronext Milan - IT0005337123 - Common Stock - Currency: EUR

0.13  0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to EVA. EVA was compared to 29 industry peers in the Automobiles industry. Both the profitability and financial health of EVA have multiple concerns. EVA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year EVA has reported negative net income.
EVA had a negative operating cash flow in the past year.
In the past 5 years EVA always reported negative net income.
EVA had a negative operating cash flow in each of the past 5 years.
EVA.MI Yearly Net Income VS EBIT VS OCF VS FCFEVA.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

EVA has a worse Return On Assets (-25.87%) than 86.21% of its industry peers.
EVA has a Return On Equity of -135.17%. This is amonst the worse of the industry: EVA underperforms 89.66% of its industry peers.
Industry RankSector Rank
ROA -25.87%
ROE -135.17%
ROIC N/A
ROA(3y)-12.54%
ROA(5y)-14.94%
ROE(3y)-59%
ROE(5y)-64.37%
ROIC(3y)N/A
ROIC(5y)N/A
EVA.MI Yearly ROA, ROE, ROICEVA.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

Looking at the Gross Margin, with a value of 35.44%, EVA belongs to the top of the industry, outperforming 86.21% of the companies in the same industry.
EVA's Gross Margin has declined in the last couple of years.
EVA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.22%
GM growth 5Y-3.46%
EVA.MI Yearly Profit, Operating, Gross MarginsEVA.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

2

2. Health

2.1 Basic Checks

EVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The debt/assets ratio for EVA is higher compared to a year ago.
EVA.MI Yearly Shares OutstandingEVA.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2020 2021 2022 2023 5M 10M 15M 20M 25M
EVA.MI Yearly Total Debt VS Total AssetsEVA.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of 0.05, we must say that EVA is in the distress zone and has some risk of bankruptcy.
EVA's Altman-Z score of 0.05 is on the low side compared to the rest of the industry. EVA is outperformed by 86.21% of its industry peers.
EVA has a Debt/Equity ratio of 2.34. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of EVA (2.34) is worse than 82.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.34
Debt/FCF N/A
Altman-Z 0.05
ROIC/WACCN/A
WACC7.27%
EVA.MI Yearly LT Debt VS Equity VS FCFEVA.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 1.95 indicates that EVA should not have too much problems paying its short term obligations.
EVA has a Current ratio of 1.95. This is in the better half of the industry: EVA outperforms 79.31% of its industry peers.
EVA has a Quick Ratio of 1.30. This is a normal value and indicates that EVA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.30, EVA belongs to the top of the industry, outperforming 82.76% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.95
Quick Ratio 1.3
EVA.MI Yearly Current Assets VS Current LiabilitesEVA.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

3

3. Growth

3.1 Past

EVA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -232.73%.
Looking at the last year, EVA shows a decrease in Revenue. The Revenue has decreased by -4.88% in the last year.
Measured over the past years, EVA shows a very negative growth in Revenue. The Revenue has been decreasing by -12.51% on average per year.
EPS 1Y (TTM)-232.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.5%
Revenue 1Y (TTM)-4.88%
Revenue growth 3Y-20.61%
Revenue growth 5Y-12.51%
Sales Q2Q%29.84%

3.2 Future

The Earnings Per Share is expected to grow by 23.43% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 14.77% on average over the next years. This is quite good.
EPS Next Y73.13%
EPS Next 2Y33.83%
EPS Next 3Y23.43%
EPS Next 5YN/A
Revenue Next Year-10.71%
Revenue Next 2Y11.8%
Revenue Next 3Y14.77%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EVA.MI Yearly Revenue VS EstimatesEVA.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M
EVA.MI Yearly EPS VS EstimatesEVA.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 -0.1 -0.2 -0.3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EVA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EVA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EVA.MI Price Earnings VS Forward Price EarningsEVA.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EVA.MI Per share dataEVA.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 -0.2

4.3 Compensation for Growth

A more expensive valuation may be justified as EVA's earnings are expected to grow with 23.43% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.83%
EPS Next 3Y23.43%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EVA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ASKOLL EVA SPA

BIT:EVA (5/5/2025, 7:00:00 PM)

0.13

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.22%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap10.34M
Analysts42.86
Price Target0.07 (-46.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-64.47%
PT rev (3m)-64.47%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)60.27%
EPS NY rev (3m)60.27%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-26.47%
Revenue NY rev (3m)-26.47%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.15
P/FCF N/A
P/OCF N/A
P/B 1.81
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.24
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.11
BVpS0.07
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.87%
ROE -135.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 35.44%
FCFM N/A
ROA(3y)-12.54%
ROA(5y)-14.94%
ROE(3y)-59%
ROE(5y)-64.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.22%
GM growth 5Y-3.46%
F-Score3
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 2.34
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 13.8%
Cap/Sales 5.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.95
Quick Ratio 1.3
Altman-Z 0.05
F-Score3
WACC7.27%
ROIC/WACCN/A
Cap/Depr(3y)14277.3%
Cap/Depr(5y)12488.9%
Cap/Sales(3y)12.75%
Cap/Sales(5y)13.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-232.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.5%
EPS Next Y73.13%
EPS Next 2Y33.83%
EPS Next 3Y23.43%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.88%
Revenue growth 3Y-20.61%
Revenue growth 5Y-12.51%
Sales Q2Q%29.84%
Revenue Next Year-10.71%
Revenue Next 2Y11.8%
Revenue Next 3Y14.77%
Revenue Next 5YN/A
EBIT growth 1Y-345.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year56.32%
EBIT Next 3Y24.03%
EBIT Next 5YN/A
FCF growth 1Y-152.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-18555.1%
OCF growth 3YN/A
OCF growth 5YN/A